In early trading on Thursday, Nebius Group’s shares surged 22.4%, making it the top performer in the Nasdaq 100 index, and marking a year-to-date gain of 116.7%. Conversely, Alnylam Pharmaceuticals experienced a significant drop of 23.7%, translating to an approximately 45.0% decline year-to-date.
Additionally, Meta Platforms fell 9.6%, while Lam Research rose 19.5% during the session.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
